No photo of Adam R Karpf

View Scopus Profile

Adam R Karpf, PhD

  • 4699 Citations
  • 35 h-Index
19972020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Adam R Karpf is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Cyclin E1 and DNA Hypomethylation in Ovarian Cancer

Karpf, A. R.

Project: Research project

Green tea-mediated inhibition of aberrant DNA hypermethylation in prostate cancer

Karpf, A. R.

National Institutes of Health

9/15/06 → 8/31/09

Project: Research project

    • Epigenetic regulation of cancer/germ-line antigen gene expression

    Karpf, A. R.

    National Institutes of Health

    5/8/06 → 12/31/12

    Project: Research project

    • Research Output

    Global dna hypomethylation in epithelial ovarian cancer: Passive demethylation and association with genomic instability

    Zhang, W., Klinkebiel, D., Barger, C. J., Pandey, S., Guda, C., Miller, A., Akers, S. N., Odunsi, K. & Karpf, A. R., Mar 2020, In : Cancers. 12, 3, 764.

    Research output: Contribution to journal › Article

    Open Access

    • Reprogramming of ovarian granulosa cells by YAP1 leads to development of high-grade cancer with mesenchymal lineage and serous features

    Lv, X., He, C., Huang, C., Hua, G., Chen, X., Timm, B. K., Maclin, V. M., Haggerty, A. A., Aust, S. K., Golden, D. M., Dave, B. J., Tseng, Y. A., Chen, L., Wang, H., Chen, P., Klinkebiel, D. L., Karpf, A. R., Dong, J., Drapkin, R. I., Rueda, B. R. & 2 others, Davis, J. S. & Wang, C., Jan 1 2020, (Accepted/In press) In : Science Bulletin.

    Research output: Contribution to journal › Article

    • Symbiotic prodrugs (SymProDs) dual targeting of NFkappaB and CDK

    Rana, S., Kour, S., Sonawane, Y. A., Robb, C. M., Contreras, J. I., Kizhake, S., Zahid, M., Karpf, A. R. & Natarajan, A., Jan 1 2020, (Accepted/In press) In : Chemical Biology and Drug Design.

    Research output: Contribution to journal › Article

    • BORIS expression in ovarian cancer precursor cells alters the CTCF cistrome and enhances invasiveness through GALNT14

    Hillman, J. C., Pugacheva, E. M., Barger, C. J., Sribenja, S., Rosario, S., Albahrani, M., Truskinovsky, A. M., Stablewski, A., Liu, S., Loukinov, D. I., Zentner, G. E., Lobanenkov, V. V., Karpf, A. R. & Higgins, M. J., Oct 1 2019, In : Molecular Cancer Research. 17, 10, p. 2051-2062 12 p.

    Research output: Contribution to journal › Article

    • 6 Scopus citations

    Epigenetic activation of POTE genes in ovarian cancer

    Sharma, A., Albahrani, M., Zhang, W., Kufel, C. N., James, S. R., Odunsi, K., Klinkebiel, D. & Karpf, A. R., Feb 1 2019, In : Epigenetics. 14, 2, p. 185-197 13 p.

    Research output: Contribution to journal › Article

    • 3 Scopus citations